Quantitative Evaluation of BCR-ABL Amount of Transcript Post Mobilization with G-CSF of Peripheral Blood Stem Cells from Chronic Myeloid Leukemia Patients in Cytogenetic Response

References

• Clift R.A., Applebaum F.R., Thomas E.D. Treatment of chronic myeloid leukemia by bone marrow transplantation. Blood 1993; 82: 1954–1956
   PubMed Web of Science ®Google Scholar
• Goldman J.M., Szydlo R., Horowitz M.M., Gale R.P., Ash R.C., Atkinson K., Dicke K.A., Gluckman E., Herzig R.H., Marmont A. Choice of pretransplantation treatment and timing of transplants for chronic myeloid leukemia in chronic phase. Blood 1993; 82: 2235–2238
   PubMed Web of Science ®Google Scholar
• The Italian Cooperative Study Group on Chronic Myeloid Leukemia Med. Progress in treatment of chronic myeloid leukemia. Interferon alpha versus conventional chemotherapy. New England Journal of Medicine 1994; 330: 820–825
   PubMed Web of Science ®Google Scholar
• The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Evaluating survival after allogenic bone marrow transplant for chronic myeloid leukemia in chronic phase: a comparison of transplant versus no-transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986. British Journal of Haematology; 1993; 85: 292–299
   PubMed Web of Science ®Google Scholar
• Coulombel L., Kalousek D.K., Eaves C.J., Gupta CM., Eaves A.C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myeloid leukemia. New England Journal of Medicine 1983; 308: 1493–1498
   PubMed Web of Science ®Google Scholar
• Daley C.Q., Goldman J.M. Autologous transplant for CML revisited. Experimental Hematology 1993; 21: 734–737
   PubMed Web of Science ®Google Scholar
• Deisseroth A.B., Zu Z., Claxton D., Hanania E.G., Fu S., Ellerson D., Goldberg L., Thomas M., Janicek K., Anderson W.F. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068–3076
   PubMed Web of Science ®Google Scholar
• Archimbaud E., Michallet M., Philip I., Charrin C., Clapisson G., Belhabri A., Guilhot F., Stryckmans P., Adeleine P., Fiere D. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia. British Journal of Haematology 1997; 99: 678–684
   PubMed Web of Science ®Google Scholar
• Carella A.M., Cunningham I., Lerma E., Dejana A., Benvenuto F., Podesta M., Celesti L., Chimirri R, Abote M., Vassallo F., Figari O., Parodi C., Sessarego M., Valbonesi M., Carlier P., Prencipe E., Gatti A.M., van den Berg D., Hoffman R., Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. Journal of Clinical Oncology 1997; 15: 1575–1582
   PubMed Web of Science ®Google Scholar
• Siebert P.D., Larrick J.W. Competitive PCR. Nature 1992; 359: 557–558
   PubMed Web of Science ®Google Scholar
• Lemoli R.M., Fortuna A., Motta M.R., Rizzi S., Giudice V., Nannetti A., Martinelli G., Cavo M., Amabile M., Mangianti S., Fogli M., Conte R., Tura S. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 1996; 87: 1625–1634
   PubMed Web of Science ®Google Scholar
• Testoni N., Martinelli G., Farabegoli P., Zaccaria A., Amabile M., Raspadori M., Pelliconi S., Zuffa E., Carboni C., Tura S. A new method of “in-cell reverse transcriptase-polymerase chain reaction” for the detection of BCR/ABL transcript, in chronic myeloid leukemia patients. Blood 1996; 87: 3822–3827
   PubMed Web of Science ®Google Scholar
• Martinelli G., Testoni N., Montefusco V., Amabile M., Saglio G., Ottaviani E., Terragna C., Bonifazzi F., de Vivo A., Pane F, Rosti G., Tura S. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse reverse-transcription-polymerase chain reaction and capillary electrophoresis. Haematologica 1998; 83: 593–601
   PubMedGoogle Scholar
• Bergamaschi G., Podesta M., Frassoni F., Rosti V., Carella A.M., Saglio G., Cazzola M. Restoration of polyclonal haematopoiesis in patients with chronic myeloid leukemia autografted with Ph negative peripheral stem cells. British Journal of Haematology 1994; 87: 867–870
   PubMed Web of Science ®Google Scholar
• Carella A.M., Frassoni F. ICE, mini-ICE or high dose hydroxyurea to mobilize Philadelphia (PH)-negative PBSC in chronic myelogenous leukaemia. British Journal of Haematology 1996; 95: 213–214
   PubMed Web of Science ®Google Scholar
• Carella A.M., Podesta M., Frassoni F., Raffo M.R., Pollicardo N., Pungolino E., Vimercati R., Sessarego M., Parodi C., Rabitti C. Collection of “normal” blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myeloid leukemia. Bone Marrow Transplantation 1993; 12: 267–271
   Google Scholar
• Carella A.M., Chimirri F., Podesta M., Pitto A., Piaggio G., Dejana A., Lerma E., Pollicardo N., Vassallo F., Soracco M., Benvenuto F., Valbonesi M., Carlier P., Vimercati R., Prencipe E., Gatti A.M., Ferrara R.A., Incagliato M., Florio G., Frassoni F. High-dose chemotherapy followed by autologous Philadelphia chromosome- negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplantation 1996; 17: 201–205
   PubMed Web of Science ®Google Scholar
• De Fabritiis P., Sandrelli A., Meloni G., Alimena G., Montefusco E., Lo Coco F, De Felice L., Mandelli F. Prolonged suppression of myeloid progenitors cell numbers after stopping alpha-INF treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplantation 1990; 6: 247–251
   PubMed Web of Science ®Google Scholar
• Pratt G., Johnson R.J., Rawstron A.C., Barnard D.L., Morgan G.J., Smith G.M. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF. Bone Marrow Transplantation 1998; 21: 455–460
   PubMed Web of Science ®Google Scholar
• Johnson R.J., Owen R.G., Child J.A., Morgan G.J., Barnard D.L., Dickinson H., Ricketts S., Rawstron A., Evans P., Woodhead V, Major K., Robinson F., Smith G.M. Mobilization of Philadelphia-negative peripheral blood monuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (figrastim). British Journal of Haematology 1996; 93: 863–868
   PubMed Web of Science ®Google Scholar
• Boquè C., Petit J., Sarra J., Cancelas J.A., Munoz J., Espanol J.I., de la Banda E., Aventin A., Berlanga J., Ferra C., Amill B., Torrico C., Azqueta C., Llucia M, Garcia J., Granena A. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia. Bone Marrow Transplantation 1996; 18: 879–884
   PubMed Web of Science ®Google Scholar
• Sessarego M., Fugazza G., Frassoni F., Defferrari R., Bruzzone R., Carella A.M. Cytogenetic analysis of hemopoietic peripheral blood cells collected by leukapher-esis after intensive chemotherapy in advanced phase Philadelphia-positive chronic myelogenous leukemia. Leukemia 1992; 6: 715–719
   PubMed Web of Science ®Google Scholar